(Total Views: 371)
Posted On: 09/14/2020 8:25:48 AM
Post# of 98
$ATNM News Article - Actinium Pharmaceuticals Announces Successful Completion of Planned Phase 1 Actimab-A CLAG-M Combination Trial in Patients with Relapsed/Refractory AML at Medical College of Wisconsin https://marketwirenews.com/news-releases/acti...38148.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
